Archives:
Welcome to the 2024 Pipeline Report. Our annual review provides an overview of research and development of innovations for diagnosing, preventing, treating, and curing HIV, hepatitis C virus (HCV), and tuberculosis (TB).
All these updates are downloadable PDFs, and we’ll be adding the three tuberculosis pipelines in the fall. Please feel free to use and share these widely in your scientific, policy, and advocacy work.
HCV
Long-Acting Therapies Trials Tracker for Hepatitis C, Opioid Use and Overdose Prevention Therapy, and Malaria
By Joelle Dountio Ofimboudem
July 2024
July 2024